|
| Wednesday, 5 November 2014, 12:20 HKT/SGT | |
| |  | |
Source: Omnicare | |
|
|
|
Cincinnati, Nov 5, 2014 - (ACN Newswire) - RxCrossroads and Advanced Care Scripts (ACS), both divisions of Omnicare Specialty Care Group (SCG), announced today that they have been selected to provide services for patients prescribed Boehringer Ingelheim's OFEV(R) capsules (nintedanib).
OFEV was recently approved by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF), a rare and fatal lung disease that affects as many as 132,000 Americans. Most people with IPF only live three to five years. OFEV is the only kinase inhibitor approved to treat IPF.
Through this partnership with Boehringer Ingelheim, RxCrossroads will perform reimbursement and support services to assist patients, caregivers and healthcare providers accessing OFEV. In addition, Advanced Care Scripts (ACS) has been selected as part of the limited distribution specialty pharmacy network, and will provide clinical support and product dispensing nationwide.
RxCrossroads provides brand support services that are known for outstanding execution and continuous enhancement of partner programs. Dedicated case management teams assist patients in navigating through the reimbursement environment. Brand support specialists are highly skilled in payer coverage, coding, reimbursement assistance, appeals and prior authorization support, and product distribution. In addition, RxCrossroads creates, implements, and executes clinical programs to support specific products and their patient populations. The company is committed to collaborating with partners to customize programs that meet the unique opportunities and challenges of each individual brand.
ACS manages and dispenses specialty medication in multiple disease categories. Its expertise in caring for patients with severe respiratory diseases enables it to provide comprehensive solutions for patients with this rare disease.
"Omnicare SCG is pleased to support this effective treatment option," said Nitin Sahney, Omnicare's Chief Executive Officer. "Through our partnership with Boehringer Ingelheim and support of OFEV, we are proud to have the opportunity to support the thousands of patients living with this unfortunate disease and provide solutions for their current unmet need."
About Omnicare Specialty Care Group
Omnicare Specialty Care Group (SCG) is a division of Omnicare, Inc., a Fortune 500 company and provider of comprehensive pharmaceutical services based in Cincinnati, Ohio. Omnicare SCG is a combination of synergistic tenured companies with a focused approach to pharmaceutical brand solutions. Together, Omnicare SCG brings specialists in reimbursement methods, clinicians practiced in medication therapy management for chronic disease states, and distribution channel expertise. Solutions are tailored to drive product access by solving challenges faced by patients and their caregivers, physicians, payers and manufacturers. Custom programs are led by a single management team across the organizational platforms, allowing coordination of resources and assets to support positive outcomes for our patients. For more information, visit www.omnicarescg.com.
About Advanced Care Scripts
Advanced Care Scripts, a specialty pharmacy, manages and dispenses specialty medications and products nationwide. It coordinates services beginning with the prescriber to simplify reimbursement and delivery of biotech therapies used to treat cancer, infectious diseases, auto-immune disorders, multiple sclerosis, hemophilia, and other disease states. Its customer service and comprehensive patient care model provides compliance and adherence support and cost-effective solutions for all classes of specialty medications.
About RxCrossroads
RxCrossroads provides tailored services to the biotechnology and pharmaceutical industries. Its partner programs are customized to meet the unique needs of each individual brand through an integrated model that provides comprehensive patient services and enhances product access, affordability, and adherence. It is also the leading provider of logistics services for plasma and other complicated therapies, as well as the management hub for large levels of consigned pharmaceutical finished goods inventory used in its patient-specific free drug distribution pharmacy program.
Contact:
Patrick C. Lee
+1-513-719-1507
patrick.lee@omnicare.com
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Omnicare via Globenewswire
Topic: Press release summary
Source: Omnicare
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
